Many findings indicated that the beginning and progression of neurodegenerative human diseases such as Alzheimer's disease (AD) and multiple sclerosis (MS) are affected by the dysregulation of PAD2 activity. The gene discussed is PADI2; the disease is myeloid sarcoma.